An error occured. Details Hide
You have unsaved pages. Restore Cancel

Institute for Health Metrics and Evaluation

The Institute for Health Metrics and Evaluation (IHME) is an independent global health research center at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME makes this information freely available so that policymakers have the evidence they need to make informed decisions about how to allocate resources to best improve population health.

All datasets:  G H
  • G
    • November 2018
      Source: Institute for Health Metrics and Evaluation
      Uploaded by: Knoema
      Accessed On: 23 November, 2018
      Select Dataset
      The Global Burden of Disease Study 2017 (GBD 2017), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 195 countries and territories and at the subnational level for a subset of countries. Developed by GBD researchers and used to help produce these estimates, the Socio-demographic Index (SDI) is a composite indicator of development status strongly correlated with health outcomes. It is the geometric mean of 0 to 1 indices of total fertility rate under the age of 25 (TFU25), mean education for those ages 15 and older (EDU15+), and lag distributed income (LDI) per capita. As a composite, a location with an SDI of 0 would have a theoretical minimum level of development relevant to health, while a location with an SDI of 1 would have a theoretical maximum level. This dataset provides tables with SDI values for all estimated GBD 2017 locations for 1950–2017 and groupings by location based on their 2017 values.
  • H
    • December 2018
      Source: Institute for Health Metrics and Evaluation
      Uploaded by: Knoema
      Accessed On: 26 December, 2018
      Select Dataset
      Global Burden of Disease Study 2016 (GBD 2016) Healthcare Access and Quality Index Based on Amenable Mortality 1990–2016. Global Burden of Disease Study 2016 (GBD 2016) estimates were used in an analysis of personal healthcare access and quality for 195 countries and territories, as well as selected subnational locations, over time. This dataset includes the following global, regional, national, and selected subnational estimates for 1990-2016: age-standardized risk-standardized death rates from 24 non-cancer causes considered amenable to healthcare; age-standardized mortality-to-incidence ratios for 8 cancers considered amenable to healthcare; and the Healthcare Access and Quality (HAQ) Index and individual scores for each of the 32 causes on a scale of 0 to 100. Code used to produce the estimates is also included. Results were published in The Lancet in May 2018 in "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Our Privacy Statement & Cookie Policy

Our website uses cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your personal cookie settings through your internet browser settings.

Privacy Policy